Home > Qtrly Results > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Sep2023]

SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Mar2022
Audited
Dec2021
UnAudited
Revenues ₹12,192 Cr ₹11,941 Cr ₹10,931 Cr ₹11,241 Cr ₹10,952 Cr ₹10,762 Cr ₹9,447 Cr ₹9,863 Cr
Expenses ₹9,013 Cr ₹8,611 Cr ₹8,129 Cr ₹8,237 Cr ₹7,996 Cr ₹8,023 Cr ₹7,267 Cr ₹7,257 Cr
Operating Income ₹3,179 Cr ₹3,330 Cr ₹2,802 Cr ₹3,004 Cr ₹2,957 Cr ₹2,739 Cr ₹2,179 Cr ₹2,606 Cr
Other Income ₹294 Cr ₹206 Cr ₹373 Cr ₹174 Cr ₹85 Cr ₹148 Cr ₹275 Cr ₹433 Cr
Interest ₹49 Cr ₹81 Cr ₹93 Cr ₹46 Cr ₹19 Cr ₹14 Cr ₹37 Cr ₹19 Cr
Depreciation ₹633 Cr ₹651 Cr ₹672 Cr ₹660 Cr ₹610 Cr ₹588 Cr ₹556 Cr ₹554 Cr
Profit Before Tax ₹2,791 Cr ₹2,481 Cr ₹2,240 Cr ₹2,471 Cr ₹2,412 Cr ₹2,285 Cr ₹-2,076 Cr ₹2,466 Cr
Profit After Tax ₹2,401 Cr ₹2,013 Cr ₹2,017 Cr ₹2,188 Cr ₹2,260 Cr ₹2,096 Cr ₹-2,222 Cr ₹2,131 Cr
EPS ₹9.90 ₹8.43 ₹8.27 ₹9.03 ₹9.43 ₹8.59 ₹-9.49 ₹8.58
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES 1% 7.9% 18.5%
DIVIS LABORATORIES -1.4% 6.6% 9.4%
CIPLA -0.5% 0.1% 8.9%
DR REDDYS LABORATORIES -1% 7.3% 29.2%
TORRENT PHARMACEUTICALS -2.3% 5.9% 27.9%
ABBOTT INDIA -2.9% -0.9% 12.5%
ZYDUS LIFESCIENCES -0.4% 8.7% 54%
ALKEM LABORATORIES 0.1% 23.7% 48.7%
LUPIN -2.9% 3.6% 63.4%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

2.11 %

Y-o-Y

11.32 %

Quarters Revenues % Change
Sep2023 ₹12,192 Cr
2.11
Jun2023 ₹11,941 Cr
9.24
Mar2023 ₹10,931 Cr
-2.76
Dec2022 ₹11,241 Cr
2.64
Sep2022 ₹10,952 Cr
1.77
Jun2022 ₹10,762 Cr
13.92
Mar2022 ₹9,447 Cr
-4.22
Dec2021 ₹9,863 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-4.52 %

Y-o-Y

7.54 %

Quarters Operating Profit % Change
Sep2023 ₹3,179 Cr
-4.52
Jun2023 ₹3,330 Cr
18.83
Mar2023 ₹2,802 Cr
-6.71
Dec2022 ₹3,004 Cr
1.60
Sep2022 ₹2,957 Cr
7.95
Jun2022 ₹2,739 Cr
25.67
Mar2022 ₹2,179 Cr
-16.38
Dec2021 ₹2,606 Cr -
Operating Margins
Q-o-Q

-6.49 %

Y-o-Y

-3.37 %

Quarters Operating Margin% % Change
Sep2023 26.08%
-6.49
Jun2023 27.89%
8.78
Mar2023 25.64%
-4.04
Dec2022 26.72%
-1.00
Sep2022 26.99%
6.05
Jun2022 25.45%
10.32
Mar2022 23.07%
-12.71
Dec2021 26.43% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

19.26 %

Y-o-Y

6.22 %

Quarters Profit After Tax % Change
Sep2023 ₹2,401 Cr
19.26
Jun2023 ₹2,013 Cr
-0.19
Mar2023 ₹2,017 Cr
-7.83
Dec2022 ₹2,188 Cr
-3.19
Sep2022 ₹2,260 Cr
7.84
Jun2022 ₹2,096 Cr
Positive
Mar2022 ₹-2,222 Cr
Negative
Dec2021 ₹2,131 Cr -
PAT Margins
Q-o-Q

16.79 %

Y-o-Y

-4.60 %

Quarters PAT Margin(%) % Change
Sep2023 19.69 %
16.79
Jun2023 16.86 %
-8.62
Mar2023 18.45 %
-5.19
Dec2022 19.46 %
-5.72
Sep2022 20.64 %
6.01
Jun2022 19.47 %
Positive
Mar2022 -23.53 %
Negative
Dec2021 21.6 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

17.44 %

Y-o-Y

4.98 %

Quarters EPS % Change
Sep2023 ₹9.9
17.44
Jun2023 ₹8.43
1.93
Mar2023 ₹8.27
-8.42
Dec2022 ₹9.03
-4.24
Sep2022 ₹9.43
9.78
Jun2022 ₹8.59
Positive
Mar2022 ₹-9.49
Negative
Dec2021 ₹8.58 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].